Microsoft (MSFT) data shows Claude is stalling against Copilot in office, reports The Information
Newsquawk Staff ·
Microsoft (MSFT) data shows Claude is stalling against Copilot in office, reports The Information.
What it means
Internal usage data surfacing via a single outlet is a familiar pattern in contested platform markets: the numbers themselves are unverifiable and typically reflect one vendor's vantage point, so the historical read is to treat them as directional colour on competitive positioning rather than settled fact. The distinction that matters here is between consumer-style AI adoption, which has historically been fluid and headline-driven, and enterprise seat deployment, where the incumbent's bundling and distribution through existing licensing agreements has tended to be the decisive channel. Microsoft pushing its own assistant through its installed office base is the classic incumbent playbook, and episodes of this kind have usually favoured the distributor over the standalone challenger on raw seat counts, even where the challenger is preferred on capability. The read-across runs both ways: to the Anthropic revenue trajectory and the valuation narratives built on it, and to Microsoft's own AI monetisation story, where seat attach and usage metrics are the proof points the market has been demanding. What is worth watching next is corroboration or pushback from the other side, any disclosure of enterprise adoption metrics in upcoming results and partner commentary, and whether the framing shifts from seats to actual consumption, which is where these platforms eventually get priced. As a single-sourced competitive datapoint, the signal is suggestive rather than conclusive.
Sources
- OpenAI has reportedly mulled a USD 5bln acquisition of Goodfire, The Information reports citing sources; Goodfire is an Anthropic-backed startup which aims to figure out how AI models act, and how to prevent them from going rogue
- Daily US Conference Calendar - 16-Nov-2026: ORCL, UNH, T, VRTX, MO
- EUROPEAN OPEN: SSNLF to manufacture STM FP chips for SPCX; NOVOB DC updates on CagriSema/Wegovy; AZN LN cuts around 600 US jobs, wins EU myasthenia gravis approval; BARC LN prepares 200 IB job cuts; STLAM IM faces Canada threat over Brampton deal
- Newsquawk Daily European Equity Opening News - 16th November 2026
- Jensen Huang's resignation from Nvidia (NVDA) has cast a shadow over companies developing open AI models to the benefit of closed frontier labs, including Anthropic and OpenAI, according to FT
Related headlines
- European Pre-Market Summary - 16th November 2026: European bourses set for a flat open9 hours ago
- Nvidia (NVDA) expands Vera CPU platform to accelerate scientific discovery21 min ago
- US EQUITY OPEN: Tech lags as NVDA sees further losses with Fed Chair Warsh set to speak later1 hour ago
- US President Trump says we need funding to get the FAA upgrade done after the ground stop; Transport Secretary Duffy is doing a great job1 hour ago
- [EARNINGS PRIMER] Nvidia (NVDA) earnings due 17th November at 21:20GMT/16:20EST; earnings call at 22:00GMT/17:00EST1 hour ago
- Tesla (TSLA) is reportedly to invest EUR 3bln in Germany's Gruenheide plant, Faz reports2 hours ago
- US PRE-MARKET MOVERS: NVDA, INTC, BIDU, NVO, LHX, SMMT, HUM, FANG, ARMK2 hours ago
- US Broker Moves: HUM upgraded at RBC Capital; COST downgraded at Northcoast3 hours ago
- Blackstone (BX) REIT to acquire Amazon (AMZN) data centres in a USD 5bln deal, Bloomberg reports4 hours ago
- Diamondback Energy (FANG) announces Core Midland Basic acquisition with the deal valued at USD 2.15bln4 hours ago
- Micron (MU) has reportedly halted work at its Taichung factory after an accident killed one person; chip production is reportedly not impacted7 hours ago
- Bunge (BG) says its vegetable oil processing facilities in Dnipro and Mykolaiv, Ukraine, were struck by drone attacks36 min ago
- Bank of America (BAC) October Master Trust Net charge off 1.96% (prev. 2.07%); Total delinquencies 1.40% (prev. 1.37%)1 hour ago
- Marvell (MRVL) and Penguin Solutions (PENG) collaborate to address data centre AI memory and accelerate inference at scale2 hours ago
- Johnson & Johnson (JNJ) to acquire Ollin Biosciences and late-stage bispecific antibody with best-in-class potential in ophthalmology; will be USD 2.2bln upfront and USD 1.125bln in milestone payments3 hours ago